Concomitant AID Expression and BCL7A Loss Associates With Accelerated Phase Progression and Imatinib Resistance in Chronic Myeloid Leukemia
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Dear Editor, The mechanisms involved in chronic myeloid leukemia (CML) progression from the chronic phase (CP) to an accelerated phase (AP) or blast crisis (BC) remain largely undetermined, but generally involve additional molecular changes besides the Philadelphia chromosome [1]. Evidence suggests that secondary BCR (breakpoint cluster region)-ABL1 (Abelson murine leukemia viral oncogene homolog 1)-dependent/independent genetic events play a critical role in blast transformation [2]. Besides BCR-ABL1 point mutations, deletions and/or rearrangements of other cancer-related genes have been associated with CML-BC [2]. Recent studies have demonstrated that aberrant activation-induced cytidine deaminase (AID) expression promotes genetic instability, eventually leading to progression and drug resistance in CML [3].
Abstract
Dear Editor, The mechanisms involved in chronic myeloid leukemia (CML) progression from the chronic phase (CP) to an accelerated phase (AP) or blast crisis (BC) remain largely undetermined, but generally involve additional molecular changes besides the Philadelphia chromosome [1]. Evidence suggests that secondary BCR (breakpoint cluster region)-ABL1 (Abelson murine leukemia viral oncogene homolog 1)-dependent/independent genetic events play a critical role in blast transformation [2]. Besides BCR-ABL1 point mutations, deletions and/or rearrangements of other cancer-related genes have been associated with CML-BC [2]. Recent studies have demonstrated that aberrant activation-induced cytidine deaminase (AID) expression promotes genetic instability, eventually leading to progression and drug resistance in CML [3].
참고문헌 (10)
- Strout MP, "Imatinib resistance and progression of CML to blast crisis : somatic hypermutation AIDing the way", Cancer Cell, 16, pp.174~176 (2009)
- Neviani P, "Genetic events other than BCR-ABL1", Curr Hematol Malig Rep, 9, pp.24~32 (2014)
- Klemm L, "The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia", Cancer Cell, 16, pp.232~245 (2009)
- Feldhahn N, "Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells", J Exp Med, 204, pp.1157~1166 (2007)
- Ugarte GD, "Wnt signaling induces transcription, spatial proximity, and translocation of fusion gene partners in human hematopoietic cells", Blood, 126, pp.1785~1789 (2015)
- Kato L, "Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes", Proc Natl Acad Sci U S A, 109, pp.2479~2484 (2012)
- Uehara T, "The tumor suppressor BCL7B functions in the Wnt signaling pathway", PLoS Genet, 11, pp.e1004921~ (2015)
- Dose M, "β-Catenin induces T-cell transformation by promoting genomic instability", Proc Natl Acad Sci U S A, 111, pp.391~396 (2014)
- Jamieson CH, "Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML", N Engl J Med, 351, pp.657~667 (2004)
- Ramiro AR, "Role of genomic instability and p53 in AID-induced c-myc-Igh translocations", Nature, 440, pp.105~109 (2006)
